Ortin Global closes trading window ahead of Q2FY27 results
- Trading window closed from October 1, 2026
- Closure lasts until 48 hours post-results declaration
- Applies to Q2FY27 and H1FY27 financial results
- Complies with SEBI insider trading regulations

*this image is generated using AI for illustrative purposes only.
Ortin Global Limited has closed its trading window for securities dealing effective October 1, 2026. The closure will remain in force until 48 hours after the declaration of unaudited financial results for the quarter and half-year ended September 30, 2026.
This action is taken pursuant to the company's Code of Conduct for Prevention of Insider Trading, adopted under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The restriction applies to all designated persons, their immediate relatives, and connected persons covered under the code.
Board meeting scheduled for financial review
The Board of Directors will convene to consider and approve the unaudited financial results for the period ending September 30, 2026. A separate intimation regarding the notice of this board meeting will be sent to the stock exchanges.
Designated persons have been instructed not to trade in the company's securities during the specified closure period. This measure ensures compliance with regulatory standards regarding price-sensitive information.
Compliance details
| Detail | Information |
|---|---|
| Trading Window Closure Start | October 1, 2026 |
| Closure End | 48 hours after results declaration |
| Reporting Period | Quarter and half-year ended September 30, 2026 |
| Regulatory Framework | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| Signed By | Prashant Prakash Sawant, Managing Director |
The filing was signed by Prashant Prakash Sawant, Managing Director, on September 22, 2026. The registered office is located in Hyderabad, Telangana.
Historical Stock Returns for Ortin Global
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.04% | -13.75% | -7.24% | -5.21% | +21.32% | -43.74% |
How might the upcoming Q2 FY27 financial results influence Ortin Global's stock volatility once the trading window reopens?
What are the potential impacts of Ortin Global's half-year performance on its future capital expenditure plans or dividend announcements?
How does this trading window closure align with broader sector trends regarding pharmaceutical companies' quarterly earnings guidance in India?


































